The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.
Colon cancer mets to liver
biosolution
CSN Member Posts: 1
Help...suggested trials/treatment.
Following is text from Ms. N's Oncologist...a treatment summary.
Dr. I., Oncologist...Patient treatment summary for Ms. N....age 48
Ms. N is under my care for metastatic cancer to the liver. Ms. N has been treated on several clinical protocols as well as trials. Her treatment has consisted of Xeloda, initially started in December of 2003, which she was treated for 10 months; however, either due to progressive disease or toxicity, she was changed to Folfox in February 2005 with progression of disease. Also she was treated following that with 5-FU, Leucovorin and Irinotecan with three cycles of this, and then indicates she was unable to tolerate the Irinotecan and changed at that point from another treating physician to myself, at which time she was treated with 5-FU, leucovorin and Avastin. She completed Avastin in September 2005 with progressive disease noted and changed to Erbitux on 9/20/05. She also had progression of disease on Erbitux, with this being discontinued on 3/30/06. Following that, she was treated with XL999-206, and also had progressive disease noted in the liver and with ascites. Her performance status is acceptable and she is presently being considered for another clinical trial.
We're looking for suggested treatments, and considering immunotherapy. Any and all recommendations appreciated.
biosolution
Following is text from Ms. N's Oncologist...a treatment summary.
Dr. I., Oncologist...Patient treatment summary for Ms. N....age 48
Ms. N is under my care for metastatic cancer to the liver. Ms. N has been treated on several clinical protocols as well as trials. Her treatment has consisted of Xeloda, initially started in December of 2003, which she was treated for 10 months; however, either due to progressive disease or toxicity, she was changed to Folfox in February 2005 with progression of disease. Also she was treated following that with 5-FU, Leucovorin and Irinotecan with three cycles of this, and then indicates she was unable to tolerate the Irinotecan and changed at that point from another treating physician to myself, at which time she was treated with 5-FU, leucovorin and Avastin. She completed Avastin in September 2005 with progressive disease noted and changed to Erbitux on 9/20/05. She also had progression of disease on Erbitux, with this being discontinued on 3/30/06. Following that, she was treated with XL999-206, and also had progressive disease noted in the liver and with ascites. Her performance status is acceptable and she is presently being considered for another clinical trial.
We're looking for suggested treatments, and considering immunotherapy. Any and all recommendations appreciated.
biosolution
Comments
Discussion Boards
- All Discussion Boards
- 6 Cancer Survivors Network Information
- 6 Welcome to CSN
- 122.5K Cancer specific
- 2.8K Anal Cancer
- 455 Bladder Cancer
- 311 Bone Cancers
- 1.6K Brain Cancer
- 28.6K Breast Cancer
- 407 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 681 Leukemia
- 802 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 242 Multiple Myeloma
- 7.2K Ovarian Cancer
- 69 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.6K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 743 Skin Cancer
- 659 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.4K Lifestyle Discussion Boards